Work

Abstract P6-18-10: A phase 1b/2 study of ribociclib plus trastuzumab for the treatment of advanced, treatment-refractory HER2-positive breast cancer

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-p6-18-10

Authors: S Goel, L Spring, R Rees, C Andrews, RK Tahara, EL Mayer, A Bardia, EP Winer, SM Tolaney

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944251997

Cites:

Cited by: 1

Related to: 10